Blog

Lockheed Martin (NYSE: LMT) has formally pulled the plug on its planned $4.4 billion acquisition of Aerojet Rocketdyne Holdings (NYSE: AJRD), bowing to regulators who opposed the deal instead of

In this clip from "The Pharma & Biotech Show" on Motley Fool Live, recorded on Feb. 2, Motley Fool contributors Keith Speights and Brian Orelli assess the pharma giant's projection that it'll return

Intel (NASDAQ: INTC) has been losing market share to Advanced Micro Devices (NASDAQ: AMD) over the past few years. A combination of chronic manufacturing delays and other missteps at Intel, good

Confluent (NASDAQ: CFLT) reported its fourth-quarter earnings results on Feb. 10, blowing past analyst expectations. The company made $120 million in revenue, which topped estimates by $10 million

Earnings season is in full swing, with many tech stocks reporting earnings in the past few weeks. With so many companies announcing their latest financial results, it might be hard to decide which

With fantastic recent quarterly results and a dividend just raised by a whopping 77%, Tractor Supply (NASDAQ: TSCO) has become a hot growth stock. In this episode of "3 Minute Stocks Updates" on

Don't look now, but value stocks are back in style -- with inflation and coming increases in interest rates as the culprit. Just to cite one example: The Vanguard Value ETF has outperformed the

Twitter (NYSE: TWTR) posted its fourth-quarter earnings report on Feb. 10. The social media company's revenue grew 22% year over year to $1.57 billion, matching analysts' expectations. But its

Broadly speaking, companies that choose to pay a dividend tend to be financially stable -- especially those that consistently raise the payout over time. And that stability often translates into

In most years, Social Security undergoes important changes. These include an annual benefits increase if a consumer price index shows costs going up, as well as an increase in how much income is

HealthEquity (NASDAQ: HQY) is the foremost provider of health savings accounts (HSAs) in the U.S., but the company got hit hard during the pandemic with an unfortunately timed major acquisition. In

In this clip from "The Pharma & Biotech Show" on Motley Fool Live, recorded on Feb. 2, Motley Fool contributor Brian Orelli analyzes Gilead's (NASDAQ: GILD) earnings report and discusses why the

Novavax (NASDAQ: NVAX) investors faced their fair share of volatility last year with the company's multiple EUA filing delays. In this clip from "The Pharma & Biotech Show" on Motley Fool Live

In this clip from "The Pharma & Biotech Show" on Motley Fool Live, recorded on Feb. 2, Motley Fool contributor Brian Orelli discusses the current drug developments of biotech companies and assesses

It's easy to pile on Moderna (NASDAQ: MRNA) these days. The sizzle from earlier in the pandemic has definitely fizzled. Moderna's current downtrend dates back to September 2021. The new year hasn't

Investors should not look for life-changing returns in the stock market to come in a day or a year. Rather, the keys to generating powerful returns are patience and commitment. Patience is needed to

With shares down by more than 45% from the highs, Shopify (NYSE: SHOP) has certainly been an underperformer recently. However, in this Motley Fool Live video clip, recorded on Jan. 27, Fool.com

Since workers at two Starbucks (NASDAQ: SBUX) stores in Buffalo, New York, voted to unionize late last year, the labor movement has taken on growing momentum in the coffee chain, spreading to a

Empire State Realty Trust (NYSE: ESRT) has primarily owned office buildings for much of its history, but recently added New York City apartment buildings to the portfolio. In this Fool Live video

Though we're pretty early on in this year's tax season, some filers might soon start seeing their refunds hit their bank accounts. If you're getting a pile of cash back from the IRS this year, you

PayPal Holdings (NASDAQ: PYPL) got off to a rough start in 2022, as investors continued their transition away from tech stocks and into value-oriented companies in order to combat rising interest

Collaboration software company Atlassian (NASDAQ: TEAM) crushed its latest earnings report in several categories, but one segment's numbers especially stood out. In this episode of "3 Minute Stocks

On Feb. 8 of last year, shares of the coronavirus vaccine developer Novavax (NASDAQ: NVAX) commanded a price near $319, with the market's fervor for its jab feeding more and more into the hype. Of

Knowing when you'll quit the workforce is a crucial part of retirement planning, but few people give as much attention to where they're going to retire. Yet it's worth thinking about if you haven't

Two of investors' all-time favorite cannabis companies released quarterly results last week. Canada-based Aurora Cannabis (NASDAQ: ACB) and Canopy Growth (NASDAQ: CGC) have made investors rich in